Actively Recruiting
Phase 2 Study of Zanubrutinib Combined with Rituximab and Venetoclax for Untreated Follicular Lymphoma Assessing Safety and Effectiveness of a Chemotherapy-Free Treatment
Led by Chinese PLA General Hospital · Updated on 2026-07-20
30
Participants Needed
1
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
Follicular lymphoma FL is the most common slow-growing non-Hodgkins lymphoma, with variable courses and usually incurable with current treatments. This trial evaluates the feasibility and effectiveness of a chemotherapy-free combination of zanubrutinib, venetoclax, and rituximab in patients with previously untreated FL. The study is a single-center, open-label, phase II clinical trial focusing on this new treatment approach due to the toxicity and relapse rates associated with standard chemotherapy-based first-line treatments. Participants will receive zanubrutinib orally and rituximab intravenously in the first three 4-week cycles. From the fourth to ninth cycles, if a complete response is achieved, they continue zanubrutinib and rituximab. If not, venetoclax is added to the regimen starting with a dose escalation in cycle 4 along with zanubrutinib and rituximab. The study treatment is given in repeated 4-week cycles, combining targeted drugs without chemotherapy. Throughout the study, participants undergo assessments including evaluation of disease response up to 6 months after treatment completion, monitoring for side effects up to 90 days after the last dose, and longer-term follow-up for progression-free and overall survival for up to two years. The research team will collect clinical data, laboratory tests, and imaging as needed to measure outcomes and ensure participant safety during the trial period, which lasts until study completion in 2027.
CONDITIONS
Brief Title
Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma
Research Team
Y
YANG LIU, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here